A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
Clinical trial NCT04485949 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04485949
- Sponsor
- Imvax
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2027-01-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.